Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Kairuilong Biotechnology is a specialized life sciences company focused on the research, development, and production of high-end chemical reagents and pharmaceutical intermediates. The company primarily serves the global pharmaceutical and biotechnology industries by providing custom synthesis services for unnatural amino acids, peptides, and complex organic molecules. Kairuilong operates research and manufacturing facilities in China, emphasizing quality control and technical innovation in chemical synthesis. Their product portfolio supports drug discovery and development processes, particularly in the field of peptide-based therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kairuilong.